Does Canada’s shrinking medical cannabis market offer lessons for other nations?

Canada’s regulated medical cannabis market has dwindled significantly from its peak, declining well before recreational marijuana legalization in October 2018 and continuing that downward trend as adult-use sales displaced purchases through regulated medical channels.

Experts say factors behind the medical market’s decline include:

The convenience of shopping at adult-use stores. Challenges for doctors in authorizing medical cannabis. A lack of tax advantages for medical cannabis clients and producers. THC potency limits that apply to both recreational and medical cannabis products.

ADVERTISEMENT

Those issues might offer lessons for other nations and jurisdictions that legalize medical marijuana first, followed by adult-use legalization.

In Canada, spending on medical cannabis products peaked about a year before recreational cannabis sales began, reaching 161 million Canadian dollars ($120 million) in the fourth quarter of 2017, according to Statistics Canada data.

The most recent data shows medical marijuana sales totaled CA$109 million

The post Does Canada’s shrinking medical cannabis market offer lessons for other nations? appeared first on GrowCola.com.

Canada’s regulated medical cannabis market has dwindled significantly from its peak, declining well before recreational marijuana legalization in October 2018… Continue reading
The post Does Canada’s shrinking medical cannabis market offer lessons for other nations? appeared first on GrowCola.com. 

Leave a Reply

Your email address will not be published. Required fields are marked *

× Whatsapp